Amerisourcebergen Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 09:30PM GMT
Lisa Christine Gill - JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good afternoon. My name is Lisa Gill. I'm the health care services analyst with JPMorgan. It is with great pleasure that I have with me this afternoon AmerisourceBergen. With me is CEO, Steve Collis; and CFO, Jim Cleary. They're going to make some opening comments, and then we'll come back for a little Q&A discussion. But Steve and Jim, thank you so much. It's great to see you guys.

Steven H. Collis - AmerisourceBergen Corporation - Chairman, President & CEO

Thank you, Lisa. It's great to be here, and welcome, Jim.

So Lisa, I'll get going. I'll start off with our slides. And we're always happy to be present at the JPMorgan conference. Of course, it's at such a prominent presence in health care that we couldn't imagine not being in January at JPMorgan conference. So we'll be providing an overview of our company today, discussing our key differentiation and growth strategies and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot